Invited Commentary: De-escalation of axillary surgery in node-positive breast cancer patients after neoadjuvant therapy

Keyphrases

• Breast Cancer Patients 100%
• Neoadjuvant Therapy 100%
• Node-positive Breast Cancer 100%
• Axillary Surgery 100%
• Invited Commentary 100%
• Neoadjuvant Chemotherapy 66%
• Immunohistochemistry 33%
• Chemotherapy Regimen 33%
• Ongoing Trials 33%
• Patient Management 33%
• Locoregional 33%
• Working Diagnosis 33%
• False Negative Rate 33%
• Nodal Disease 33%
• Overall Outcome 33%
• Surgical Approach 33%
• Axilla 33%
• Axillary Lymph Node Dissection 33%
• Surgical Management 33%
• Surgical Technique 33%
• Lymphedema 33%
• Minimally Invasive Approach 33%
• Dual Tracer 33%
• Morbidity Risk 33%
• Nodal Response 33%
• Limited Range of Motion 33%
• Tracer Technique 33%

Medicine and Dentistry

• Breast Cancer 100%
• Neoadjuvant Therapy 100%
• Axillary Surgery 100%
• Diseases 66%
• Neoadjuvant Chemotherapy 66%
• Surgery 33%
• Immunohistochemistry 33%
• Biopsy Technique 33%
• Retroperitoneal Lymph Node Dissection 33%
• Chemotherapy 33%
• False Negative Result 33%
• Surgical Technique 33%
• Surgical Approach 33%
• Axilla 33%
• Axillary Lymph Node 33%
• Morbidity 33%
• Radioactive Tracer 33%
• Lymphedema 33%
• Range of Motion 33%